Long COVID is a chronic condition that develops after a COVID-19 infection and lasts at least three months. It can affect nearly every organ system in the body, producing more than 200 documented symptoms. Roughly 10% to 26% of adults and about 4% of children develop it after infection, though the range depends on how it’s measured.
How Long COVID Is Diagnosed
There is no blood test, scan, or biomarker that can confirm long COVID. A positive COVID test isn’t even required for diagnosis. Instead, a healthcare provider evaluates your health history, any prior COVID diagnosis (whether confirmed by a test, symptoms, or known exposure), and your current symptoms. If those symptoms have persisted for at least three months after infection, long COVID is the working diagnosis.
This can be frustrating. Many people go through rounds of normal lab results and imaging while still feeling significantly unwell. The lack of a definitive test doesn’t mean the condition isn’t real. It means the tools haven’t caught up yet.
Common Symptoms by Body System
The three most frequently reported symptoms are fatigue that disrupts daily life, brain fog (difficulty thinking or concentrating), and post-exertional malaise, which is a worsening of symptoms after physical or mental effort. But the full picture is much broader.
- General: Persistent fatigue, fever, symptoms worsening after exertion
- Respiratory and heart: Shortness of breath, cough, chest pain, heart palpitations
- Neurological: Brain fog, headaches, sleep problems, dizziness on standing, pins-and-needles sensations, changes in smell or taste, depression, anxiety
- Digestive: Diarrhea, stomach pain, constipation
- Other: Joint or muscle pain, rash, changes in menstrual cycles
Symptoms can appear in clusters or shift over time. Some people deal primarily with cognitive problems, others with cardiovascular symptoms, and many with overlapping combinations that fluctuate week to week.
Post-Exertional Malaise: The Crash Cycle
Post-exertional malaise, often called PEM, deserves special attention because it changes how people need to manage their daily lives. It’s a worsening of symptoms following activity that previously would have been manageable: a short walk, a focused work session, even a stressful conversation. The crash typically hits 12 to 48 hours after the activity and can last days or weeks.
PEM is a hallmark of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and many people with long COVID meet criteria for that condition. The key management strategy is pacing: carefully planning activity levels to stay within limits that don’t trigger a crash. This isn’t about gradually pushing through. Overexertion can set recovery back significantly, so activity plans need to be built around each person’s current capacity, not where they want to be.
Why Long COVID Happens
Scientists have identified several mechanisms that likely work together, though the exact combination varies from person to person.
One leading theory is viral persistence. Months after the initial infection, researchers have found viral fragments, including spike protein and viral genetic material, in the gut and urinary tract of people with long COVID. The virus may hide in tissue reservoirs and repeatedly trigger immune responses long after the acute illness has resolved. There’s even evidence that the virus can infect gut bacteria, disrupting the balance of the microbiome.
A second mechanism is immune dysregulation. During acute COVID, the immune system can launch an exaggerated inflammatory response, sometimes called a cytokine storm. In some people, this overreaction doesn’t fully resolve. The infection can also deplete certain immune cells, creating a paradox where the body is simultaneously inflamed and immunocompromised. On top of that, the immune system may start producing autoantibodies that attack the body’s own tissues. Autoantibodies have been found in over half of hospitalized COVID patients in some studies.
A third piece involves microclots. Tiny, abnormal blood clots made of clumped fibrin (a clotting protein) have been found in the blood of long COVID patients. These microclots, combined with overactivated platelets, may restrict blood flow through small vessels and contribute to fatigue, brain fog, and the widespread inflammation that characterizes the condition.
Who Is Most at Risk
Women are about 50% more likely to develop long COVID than men. People who were hospitalized or had a severe acute infection face roughly 2.4 times the risk. Having pre-existing conditions like diabetes or high blood pressure raises the odds by about 60%.
The role of age is less clear-cut. Some studies have found older adults at higher risk, while others show no consistent relationship once other factors are accounted for. Long COVID affects people across all age groups, including children and young adults who had mild initial infections.
Vaccination before infection appears to reduce the risk. A systematic review of 12 studies found that 10 showed a significant reduction in long COVID incidence among vaccinated people. The degree of protection varied widely across studies, but the overall trend was consistent: more doses generally correlated with lower odds. One study found that three vaccine doses reduced the odds of having long COVID at one month post-infection by 84%.
Long COVID in Children
About 4% of children develop long COVID after infection. Symptoms can look different than in adults: dizziness, increased heart rate, and fatigue are common, and the condition can affect the heart, brain, and lungs. Children can also develop entirely new conditions after a COVID infection, including diabetes, ME/CFS, or multisystem inflammatory syndrome in children (MIS-C), a serious inflammatory reaction that can affect multiple organs.
Recovery Outlook
A large population study tracking people for two years after infection found that about 18.5% still reported not having recovered at 12 months. At 24 months, that number had only dipped slightly to 17.2%. The prevalence of COVID-related symptoms dropped from roughly 29% at six months to about 18% at two years.
The pattern suggests that most improvement happens within the first year. After that, recovery plateaus for a significant minority. Some people do continue to improve gradually beyond two years, but a substantial group remains chronically affected.
How Long COVID Is Managed
There is no single treatment that resolves long COVID. Management focuses on reducing the burden of the most disruptive symptoms and improving day-to-day function. Because the condition overlaps with ME/CFS, fibromyalgia, dysautonomia, and mast cell activation syndrome, treatment approaches borrowed from those conditions often help.
A typical plan might include pacing strategies to prevent PEM crashes, a carefully designed rehabilitation program, optimization of any underlying conditions like asthma or diabetes, and symptom diaries to track what triggers flares and what helps. Medications are tailored to specific symptoms rather than the condition as a whole.
One of the most important parts of care is validation. Many people with long COVID spend months being told their symptoms are anxiety or deconditioning before receiving a diagnosis. Having a provider who takes the condition seriously, completes a thorough evaluation, and connects patients with appropriate support makes a measurable difference in outcomes and quality of life.